We are live on ! Find out more
FBT icon

First Trust NYSE Arca Biotechnology Index Fund

210 hedge funds and large institutions have $818M invested in First Trust NYSE Arca Biotechnology Index Fund in 2019 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 51 increasing their positions, 73 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 25 (+3)

104% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 25

82% more call options, than puts

Call options by funds: $2.14M | Put options by funds: $1.18M

12% more funds holding

Funds holding: 188210 (+22)

10% more capital invested

Capital invested by funds: $744M → $818M (+$73.7M)

1.9% more ownership

Funds ownership: 43.64%45.54% (+1.9%)

30% less repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 73

Holders
210
Holders Change
+22
Holders Change %
+11.7%
% of All Funds
4.14%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.1%
New
51
Increased
51
Reduced
73
Closed
25
Calls
$2.14M
Puts
$1.18M
Net Calls
+$968K
Net Calls Change
+$95K
Name Holding Trade Value Shares
Change
Change in
Stake
HCIA
101
Hochman Cole Investment Advisors
Illinois
$432K
PFA
102
Pinnacle Family Advisors
Missouri
$429K +$396K +2,887 New
BCM
103
Beck Capital Management
Texas
$422K +$389K +2,835 New
LFAS
104
Level Four Advisory Services
Texas
$418K +$385K +2,804 New
SWM
105
Sequoia Wealth Management
Illinois
$396K -$393K -2,863 -52%
CA
106
Clearstead Advisors
Ohio
$377K
CAS
107
Cascadia Advisory Services
Oregon
$370K +$341K +2,486 New
CAM
108
Cozad Asset Management
Illinois
$368K -$172K -1,256 -34%
CPIA
109
Cornell Pochily Investment Advisors
New York
$365K -$824 -6 -0.2%
SI
110
Stephens Inc
Arkansas
$364K -$53.3K -388 -14%
JIP
111
Jaffetilchin Investment Partners
Florida
$334K +$10.7K +78 +4%
FFN
112
Focus Financial Network
Minnesota
$329K -$15K -109 -5%
RCA
113
Ranch Capital Advisors
Florida
$329K +$119K +868 +65%
JCM
114
Jacobi Capital Management
Pennsylvania
$323K -$7.14K -52 -2%
NA
115
NewEdge Advisors
Louisiana
$320K -$227K -1,656 -43%
KA
116
Kovack Advisors
Florida
$319K -$1.37K -10 -0.5%
Creative Planning
117
Creative Planning
Kansas
$292K -$14.4K -105 -5%
MAP
118
Milestone Advisory Partners
North Carolina
$290K
SFP
119
Shepherd Financial Partners
Massachusetts
$284K
BRC
120
Bell Rock Capital
Delaware
$278K -$71.7K -522 -22%
GRP
121
Global Retirement Partners
California
$272K
VFA
122
Voya Financial Advisors
Connecticut
$270K +$23.2K +169 +10%
HIA
123
Harbor Investment Advisory
Maryland
$270K +$249K +1,815 New
EAM
124
Eukles Asset Management
Ohio
$269K -$199K -1,449 -45%
EPA
125
Element Pointe Advisors
Florida
$263K

FBT Hedge Fund Activity: Q4 2019 in Review

210 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q4 2019, worth a combined $818M — up 9.9% from $744M a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new FBT positions and 25 closed out — a net gain of 26 holders — while 51 added to existing stakes and 73 trimmed.

The largest buyer was Raymond James Financial Services Advisors, adding an estimated $7.85M. The largest seller was UBS Group, cutting an estimated $16.3M.

  • 210 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q4 2019, up from 188 in Q3 2019.
  • Funds reported $818M of First Trust NYSE Arca Biotechnology Index Fund stock for Q4 2019, up 9.9% quarter-over-quarter.
  • 51 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q4 2019 and 25 closed out, a net change of +26 holders.
  • The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q4 2019 was Raymond James Financial Services Advisors, an estimated $7.85M added.
  • The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q4 2019 was UBS Group, an estimated $16.3M sold.

Based on aggregated 13F filings for Q4 2019.